Impacts of COVID-19 on the mental health of graduate students in the health area of a university in Ceará, Brazil
DOI:
https://doi.org/10.14450/2318-9312.v35.e1.a2023.pp52-63Keywords:
pharmaceutical intervention, prescription, rational use of medicines, hospitalAbstract
Graduate students experience an environment of intense demands. The COVID-19 pandemic caused the suspension of face-to-face academic activities, affecting the daily lives of these people. This study aimed to analyze the impact of COVID-19 on the mental health of stricto sensu graduate students in the health area of a public university in Ceará regardind the use of antidepressant and anxiolytic drugs. This cross-sectional, descriptive study uses a remote questionnaire from August 2021 to February 2022.Socio-demographic, clinical, medication use, and data from the “Self-Report Questionnaire” test were collected. 217 master’s and doctoral students participated in the study, most of them female (71%), between 21 and 30 years old (55.3%) and without children (76.5%). The results showed an increase in the number of graduate students with symptoms of anxiety and/or depression after the pandemic (23.4%). Among the main symptoms, there is a strong indication of mental suffering (60.4%), nervousness, tension or concern (77.9%), sadness (55.3%), difficulties in carrying out daily activities with satisfaction (55.4%), and tiredness (65%). These symptoms were most prevalent among women. Regarding medication use (anxiolytics/antidepressants), 38.2% responded positively. Of these, 40.9% increased the dosage, and 79.5% experienced adverse reactions. In this way, the COVID-19 pandemic negatively affected graduate students’ mental health, reinforcing the need for universities to develop strategies to mitigate these students’ emotional suffering.
Downloads
Published
2023-04-24
How to Cite
Neves, K. R. T., Martins, S. de O., Tavares, K. C., & Aragão, G. F. (2023). Impacts of COVID-19 on the mental health of graduate students in the health area of a university in Ceará, Brazil. Infarma - Pharmaceutical Sciences, 35(1), 52–63. https://doi.org/10.14450/2318-9312.v35.e1.a2023.pp52-63
Issue
Section
Original article
License
Authors who publish in this journal agree to the following terms:
- Authors retain the copyright and grant the journal the right of first publication, with the work simultaneously licensed under the Licença Creative Commons Attribution which allows the sharing of work with acknowledgment of authorship and initial publication in this journal.
- Authors are authorized to take additional contracts separately, for non-exclusive distribution of the version of the work published in this journal (e.g. publish in institutional repository or as a book chapter), with acknowledgment of authorship and initial publication in this journal.
- Authors are allowed and encouraged to publish and distribute their work online (e.g. in institutional repositories or on their personal page) at any point before or during the editorial process, as this can generate productive changes as well as increase the impact and Citation of published work (See O Efeito do Acesso Livre ).